참고문헌
- Adams LD, Geary RL, Li J, Rossini A, Schwartz SM. Expression profiling identifies smooth muscle cell diversity within human intima and plaque fibrous cap: loss of RGS5 distinguishes the cap. Arterioscler Thromb Vasc Biol. 2006. 26: 319-325.
- Amalinei C, Caruntu ID, Giusca SE, Balan RA. Matrix metalloproteinases involvement in pathologic conditions. Rom J Morphol Embryol. 2010. 51: 215-228.
- Amorino GP, Hoover RL. Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production. Am J Pathol. 1998. 152: 199-207.
- Armstrong C, Abilleira S, Sitzer M, Markus HS, Bevan S. Polymorphisms in MMP family and TIMP genes and carotid artery intima-media thickness. Stroke. 2007. 38: 2895-2899. https://doi.org/10.1161/STROKEAHA.107.491696
- Bar-Or A, Nuttall RK, Duddy M, Alter A, Kim HJ, Ifergan I, Pennington CJ, Bourgoin P, Edwards DR, Yong VW. Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain. 2003. 126: 2738-2749. https://doi.org/10.1093/brain/awg285
- Fanjul-Fernandez M, Folgueras AR, Cabrera S, Lopez-Otin C. Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta. 2010. 1803: 3-19. https://doi.org/10.1016/j.bbamcr.2009.07.004
- Geurian K, Pinson JB, Weart CW. The triglyceride connection in atherosclerosis. Ann Pharmacother. 1992. 26: 1109-1117. https://doi.org/10.1177/106002809202600913
- Hojilla CV, Mohammed FF, Khokha R. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer. 2003. 89: 1817-1821. https://doi.org/10.1038/sj.bjc.6601327
- Johnson JL. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability. Expert Rev Cardiovasc Ther. 2007. 5: 265-282. https://doi.org/10.1586/14779072.5.2.265
- Kannel WB, Vasan RS. Triglycerides as vascular risk factors: new epidemiologic insights. Curr Opin Cardiol. 2009. 24: 345-350. https://doi.org/10.1097/HCO.0b013e32832c1284
- Ley K, Miller YI, Hedrick CC. Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol. 2011. 31: 1506-1516. https://doi.org/10.1161/ATVBAHA.110.221127
- Lim J, Cho Y, Lee DH, Jung BC, Kang HS, Kim T-J, Rhee K-J, Kim TU, Kim YS. Upregulation of MMP is mediated by MEK1 activation during differentiation of monocyte into macrophage. J Exp Biomed Sci. 2012. 18: 104-111.
- Matias-Roman S, Galvez BG, Genis L, Yanez-Mo M, de la Rosa G, Sanchez-Mateos P, Sanchez-Madrid F, Arroyo AG. Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium. Blood. 2005. 105: 3956-3964. https://doi.org/10.1182/blood-2004-06-2382
- Miyagawa J, Hanafusa T. Mechanism of atherosclerosis in diabetes: altered cytokine network in the vascular wall. Nihon Rinsho. 1999. 57: 601-606.
- Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006. 69: 562-573. https://doi.org/10.1016/j.cardiores.2005.12.002
- Newby AC. Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol. 2008. 28: 2108-2114. https://doi.org/10.1161/ATVBAHA.108.173898
- Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of nflammation and innate immunity. Nat Rev Immunol. 2004. 4: 617-629. https://doi.org/10.1038/nri1418
- Rivera S, Khrestchatisky M, Kaczmarek L, Rosenberg GA, Jaworski DM. Metzincin proteases and their inhibitors: foes or friends in nervous system physiology? J Neuroscience. 2010. 30: 15337-15357. https://doi.org/10.1523/JNEUROSCI.3467-10.2010
- Ross R. Atherosclerosis: current understanding of mechanisms and future strategies in therapy. Transplant Proc. 1993. 25: 2041-2043.
- Schafers M, Schober O, Hermann S. Matrix-metalloproteinases as imaging targets for inflammatory activity in atherosclerotic plaques. J Nucl Med. 2010. 51: 663-666. https://doi.org/10.2967/jnumed.109.065698
- Shimokawa H. Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol. 1999. 31: 23-37. https://doi.org/10.1006/jmcc.1998.0841
- Souza HP, Frediani D, Cobra AL, Moretti AI, Jurado MC, Fernandes TR, Cardounel AJ, Zweier JL, Tostes RC. Angiotensin II modulates CD40 expression in vascular smooth muscle cells. Clin Sci (Lond). 2009. 116: 423-431. https://doi.org/10.1042/CS20080155
- Stalenhoef AF, de Graaf J. Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL. Curr Opin Lipidol. 2008. 19: 355-361. https://doi.org/10.1097/MOL.0b013e328304b63c
- Tabas I. Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress. Antioxid Redox Signal. 2009. 11: 2333-2339. https://doi.org/10.1089/ars.2009.2469
- Thorp E, Tabas I. Mechanisms and consequences of efferocytosis in advanced atherosclerosis. J Leukoc Biol. 2009. 86: 1089-1095. https://doi.org/10.1189/jlb.0209115
- Valdivielso P, Sanchez-Chaparro MA, Calvo-Bonacho E, Cabrera-Sierra M, Sainz-Gutierrez JC, Fernandez-Labandera C, Fernandez-Meseguer A, Quevedo-Aguado L, Moraga MR, Galvez-Moraleda A, Gonzalez-Quintela A, Roman-Garcia J. Association of moderate and severe hypertriglyceridemia with obesity, diabetes mellitus and vascular disease in the Spanish working population: results of the ICARIA study. Atherosclerosis. 2009. 207: 573-578. https://doi.org/10.1016/j.atherosclerosis.2009.05.024